Case Note & Summary
The case involved Medley Pharmaceuticals Ltd. challenging the excise duty levied on physician samples distributed as free samples. The appellant contended that these samples, being statutorily prohibited from sale under the Drugs and Cosmetics Act, 1940, should not be considered excisable goods. The Commissioner of Central Excise had previously ruled that the samples were subject to excise duty, leading to the appeals. The Supreme Court examined the definitions of excisable goods, emphasizing that for goods to be excisable, they must be both movable and marketable. The court referenced various precedents to clarify that marketability is a crucial criterion for excise duty. It concluded that physician samples, while manufactured, are not marketable due to their prohibition from sale, thus not qualifying as excisable goods. However, the court also addressed the method of valuation for those samples that are considered excisable, ruling that they should be valued on a pro-rata basis. The court allowed the appeal regarding the valuation and remitted the matter to the Adjudicating Authority for further action, while dismissing the other appeals. The decision reinforced the distinction between the regulatory framework of the Drugs Act and the revenue-generating purpose of the Excise Act, asserting that statutory prohibitions do not negate the duty on manufacture.
Headnote
A) Excise Law - Excisable Goods - Definition and Marketability - Physician samples are not excisable goods as they are statutorily prohibited from being sold under the Drugs and Cosmetics Act, 1940. The court held that for goods to be excisable, they must be marketable, which physician samples are not due to the prohibition on their sale (Paras 5-6). B) Excise Law - Valuation of Goods - The valuation of physician samples for excise duty must be on a pro-rata basis as per the established precedent. The court directed that the goods be valued accordingly for the relevant period (Paras 41-42).
Issue of Consideration
Whether physician samples manufactured and distributed as free samples are excisable goods and how they should be valued for excise duty.
Final Decision
The Supreme Court allowed Civil Appeal No. 3626 of 2005, remitting the matter to the Adjudicating Authority for valuation on a pro-rata basis. Civil Appeal Nos. 1354-1355 of 2010 were dismissed.
Law Points
- Excise duty
- marketability
- valuation of goods
- physician samples
- statutory prohibition
